Premium
Cholesterol‐induced astrocyte activation is associated with increased amyloid precursor protein expression and processing
Author(s) -
AvilaMuñoz Evangelina,
Arias Clorinda
Publication year - 2015
Publication title -
glia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.954
H-Index - 164
eISSN - 1098-1136
pISSN - 0894-1491
DOI - 10.1002/glia.22874
Subject(s) - astrocyte , biology , amyloid precursor protein , cholesterol , neuroscience , amyloid (mycology) , microbiology and biotechnology , biochemistry , alzheimer's disease , medicine , central nervous system , disease , botany
Cholesterol is essential for maintaining lipid raft integrity and has been regarded as a crucial regulatory factor for amyloidogenesis in Alzheimer's disease (AD). The vast majority of studies on amyloid precursor protein (APP) metabolism and amyloid β‐protein (Aβ) production have focused on neurons. The role of astrocytes remains largely unexplored, despite the presence of activated astrocytes in the brains of most patients with AD and in transgenic models of the disease. The role of cholesterol in Aβ production has been thoroughly studied in neurons and attributed to the participation of lipid rafts in APP metabolism. Thus, in this study, we analyzed the effect of cholesterol loading in astrocytes and analyzed the expression and processing of APP. We found that cholesterol exposure induced astrocyte activation, increased APP content, and enhanced the interaction of APP with BACE‐1. These effects were associated with an enrichment of ganglioside GM1‐cholesterol patches in the astrocyte membrane and with increased ROS production. GLIA 2015;63:2010–2022